<?xml version="1.0" encoding="UTF-8"?>
<p id="Par27">Second, hospitals in Germany are reimbursed per patient, not per apheresis session versus French hospitals being reimbursed per apheresis session. German centers have little financial incentive to carry out additional apheresis sessions to obtain higher CD34+ cell yields, as long as sufficient stem cells have been collected to proceed to transplantation. Therefore, the number of apheresis sessions per patient was already relatively low in Germany during the pre-plerixafor era (1.9 sessions per patient in Germany vs. 2.4 sessions in France)[
 <xref ref-type="bibr" rid="CR17">17</xref>].
</p>
